Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

• Status: Completed
• Trial end date: 2020-04-25

Summary

This experimental non-randomized clinical study is aimed at comparing the efficacy and safety assessment of the proposed topical therapy algorithms with the use of topical calcineurin inhibitors in reducing the severity of atopic dermatitis and the degree of development of transcutaneous sensitization in children of the first year of life.

• Phase: Phase 4

Details

• Lead Sponsor: National Medical Research Center for Children's Health, Russian Federation
• Treatments: Methylprednisolone; Methylprednisolone aceponate; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Pimecrolimus; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate